Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.3 USD | -1.21% | -1.79% | +22.98% |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
May. 15 | UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.98% | 8.3B | |
+13.97% | 15.93B | |
-26.39% | 11.07B | |
-2.51% | 6.78B | |
+46.68% | 2.13B | |
+7.52% | 1.62B | |
+12.89% | 945M | |
+22.56% | 946M | |
-16.66% | 593M | |
-9.78% | 636M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- UBS Raises Crane's Price Target to $152 From $120, Maintains Neutral Rating